Global Nasal Cannula Market, by Product Type (Curved prong cannula, Flared prong cannula, Straight prong cannula, Curved and flared prong cannula) by Material (Plastic, Silicon ) by Application (Asthma, Lung cancer, Chronic bronchitis, Pulmonary embolism, COPD, Emphysema, Cystic fibrosis, and Pneumonia ) by End User (Hospital, Long term care center, Home care settings, Ambulatory surgical centers, and Others) and by Region (North America, Latin America, Europe, Asia Pacific, Middle East, and Africa), is estimated to be valued at US$ 6,801.7 million in 2021 and is expected to exhibit a CAGR of 6.4 % during the forecast period (2021-2028).

Market players are engaged in manufacturing the nasal cannula as it does not require approval from regulatory authorities, but quality is a concern for patient safety, which is expected to increase the growth of the global nasal cannula market over the forecast period. For instance, To avoid the marketing of unauthorized devices that can harm patients the Philippines FDA issued a letter advising healthcare services and the general public on October 8, 2019 , not to purchase unregistered medical devices such as intersurgical adult nasal cannula with straight prong with tube until the certificate of the product registration is issued, The Philippines FDA issued this letter as a concern for the safety of patients, which is expected to grow the nasal cannula market.

Increasing research and development activities by the market players and research institutes are expected to drive the growth of the global nasal cannula market over the forecast period. For instance, on June 4, 2019, a study published in PubMed by University Hospital Mater Domini, They investigated the use of a High Flow Nasal Cannula (HFNC) and Continuous Positive Airway Pressure Therapy (CPAP). This machine helps patients with sleeping disorders such as obstructive apnea, where patients face difficulty with breathing problems. This study concluded as no adverse effects were observed in patients. Also, 30 L/min supply of oxygen is best for the combination of HFNC and CPAP.

Global Nasal Cannula Market- Impact of Coronavirus (COVID – 19) Pandemic

The coronavirus disease (COVID-19) pandemic is expected to drive growth of the global nasal cannula market over the forecast period. COVID-19 is the recent pandemic outbreak which was first reported on December 31, 2019 in Wuhan, China. The World Health Organization declared coronavirus disease (COVID-19) as a pandemic on March 11, 2020. According to the World Health Organization (WHO) Weekly epidemiological update on COVID-19, the number of new cases and deaths continued to decrease, with nearly 254 million cases of COVID-19 were reported globally and with just under 5,120,712 deaths till November 18,  2021.

Increasing research and development activities by research institutes are expected to increase the growth of the global nasal cannula market over the forecast period. For instance, on September 29, 2020, a study published in PubMed on the application of a surgical mask on top of a high-flow nasal cannula can improve oxygenation in critically ill patients affected by COVID-19 and suffering from hypoxemic respiratory failure. As the chances of infection are high in critically ill patients through airflow due to coughing or through nostrils, this method can help to reduce the transmission of any other virus in the patient's body.

 Browse 38 Market Data Tables and 26 Figures spread through 173 Pages and in-depth TOC on Global Nasal Cannula Market, by Product Type (Curved prong cannula, Flared prong cannula, Straight prong cannula, Curved and flared prong cannula) by Material (Plastic and Silicon ) by Application (Asthma, Lung cancer, Chronic bronchitis, Pulmonary embolism, COPD, Emphysema, Cystic fibrosis, and Pneumonia ) by End User (Hospital, Long term care center, Home care settings, Ambulatory surgical centers, and Others) and by Region (North America, Latin America, Europe, Asia Pacific, Middle East, and Africa).

To know the latest trends and insights prevalent in the nasal cannula market, click the link below:

https://www.coherentmarketinsights.com/market-insight/nasal-cannula-market-2694

Increasing prevalence of respiratory diseases globally is expected to drive the growth of the global nasal cannula market, over the forecast period. For instance, according to the statistical data published in the Allergy and Asthma Network, in 2020, globally, approximately 51.6 % of the children are suffering from asthma and 43.6% of the adults are suffering from asthma. The following pie chart is indicating the above mentioned data for asthma rate of patients from 2020.

Key Takeaways of the Global Nasal Cannula Market:

  • The global nasal cannula market is expected to exhibit a CAGR of 6.4 % over the forecast period (2021-2028), owing to growth in potential markets, especially in Europe. While North America region accounted for the major market share in 2020.
  • Market players are engaged in developing devices for providing oxygen supply to the patients suffering from respiratory diseases, which is expected to drive the growth of nasal cannula. For instance, on February 23, 2021 Masimo is manufacturer of noninvasive patient monitoring technologies, ventilation solution and home monitoring devices, has announced softFlow High-Flow Nasal Cannula Therapy which provides warmed and humidified respiratory gases to the patients. This device is allowing patients to walk, eat during treatment which is not possible with other masks.
  • Some of the major players operating in the global nasal cannula market include Medtronic PLC, Maquet Holding B.V. & Co.KG, Edward Life sciences corp., Terumo Crop., Sorin Group, Medin Medical innovations, Flexicare Medical, Smiths Medical, Teleflex Incorporated, Vapothem Inc., Salter Labs, Well Lead Medical Co. Ltd., Drive Devilbiss international, Allied Healthcare products, Besmed Health Business Cor, and Fairmont Medical.

EXISTING CLIENTELE

Joining thousands of companies around the world committed to making the Excellent Business Solutions.

View All Our Clients
trusted clients logo